Page last updated: 2024-10-22

amifostine anhydrous and Anaphylaxis

amifostine anhydrous has been researched along with Anaphylaxis in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.

Research Excerpts

ExcerptRelevanceReference
"Dermatomyositis is associated with malignancy in approximately 20-25% of cases."2.41Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. ( Clarke, SJ; Clifford, A; Izard, M; Vardy, J; Wong, E, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vardy, J1
Wong, E1
Izard, M1
Clifford, A1
Clarke, SJ1

Reviews

1 review available for amifostine anhydrous and Anaphylaxis

ArticleYear
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.
    Anti-cancer drugs, 2002, Volume: 13, Issue:3

    Topics: Amifostine; Anaphylaxis; Combined Modality Therapy; Dermatomyositis; Humans; Magnetic Resonance Imag

2002